Hyperediting of human T-cell leukemia virus type 2 and simian T-cell leukemia virus type 3 by the dsRNA adenosine deaminase ADAR-1

Journal of General Virology

Volumn 93, Issue PART 12, 2012, Pages 2646-2651

  Ko, Nga Ling ^a   Birlouez, Emmanuel ^a   Wain Hobson, Simon ^a   Mahieux, Renaud ^a,b   Vartanian, Jean Pierre ^a  

^a CNRS   (France)

^b University Lyon i   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; ADENOSINE DEAMINASES ACTING ON RNA 1; DINUCLEOTIDE; DOUBLE STRANDED RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 2; IN VITRO STUDY; IN VIVO STUDY; MUTATION RATE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROVIRUS; RNA EDITING; SIMIAN T CELL LEUKEMIA VIRUS TYPE 3; VIRUS GENOME;

ADENOSINE; ADENOSINE DEAMINASE; ANIMALS; BASE SEQUENCE; GENOME, VIRAL; HEK293 CELLS; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; POLYMERASE CHAIN REACTION; RNA EDITING; RNA, VIRAL; SEQUENCE HOMOLOGY, NUCLEIC ACID; SIMIAN T-LYMPHOTROPIC VIRUS 3;

ARA; HUMAN T-LYMPHOTROPIC VIRUS 2; RNA VIRUSES; SIMIAN IMMUNODEFICIENCY VIRUS - AGM; SIMIAN T-LYMPHOTROPIC VIRUS 3;

EID: 84869228793     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.045146-0     Document Type: Article

References (37)

1. Bass, B. L. (1997). RNA editing and hypermutation by adenosine deamination. Trends Biochem Sci 22, 157-162.
2. Bass, B. L. (2002). RNA editing by adenosine deaminases that act on RNA. Annu Rev Biochem 71, 817-846.
3. Calattini, S., Chevalier, S. A., Duprez, R., Afonso, P., Froment, A., Gessain, A. & Mahieux, R. (2006). Human T-cell lymphotropic virus type 3: complete nucleotide sequence and characterization of the human tax3 protein. J Virol 80, 9876-9888.
4. Cattaneo, R., Rebmann, G., Schmid, A., Baczko, K., ter Meulen, V. & Billeter, M. A. (1987). Altered transcription of a defective measles virus genome derived from a diseased human brain. EMBO J 6, 681-688.
5. Cattaneo, R., Schmid, A., Eschle, D., Baczko, K., ter Meulen, V. & Billeter, M. A. (1988). Biased hypermutation and other genetic changes in defective measles viruses in human brain infections. Cell 55, 255-265.
6. Chen, I. S., Quan, S. G. & Golde, D. W. (1983). Human T-cell leukemia virus type II transforms normal human lymphocytes. Proc Natl Acad Sci U S A 80, 7006-7009.
7. Chen, C. X., Cho, D. S., Wang, Q., Lai, F., Carter, K. C. & Nishikura, K. (2000). A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single-and double-stranded RNA binding domains. RNA 6, 755-767.
8. Chevalier, S. A., Walic, M., Calattini, S., Mallet, A., Prévost, M. C., Gessain, A. & Mahieux, R. (2007). Construction and characterization of a full-length infectious simian T-cell lymphotropic virus type 3 molecular clone. J Virol 81, 6276-6285.
9. Doria, M., Neri, F., Gallo, A., Farace, M. G. & Michienzi, A. (2009). Editing of HIV-1 RNA by the double-stranded RNA deaminase ADAR1 stimulates viral infection. Nucleic Acids Res 37, 5848-5858.
10. Douceron, E., Kaidarova, Z., Miyazato, P., Matsuoka, M., Murphy, E. L. & Mahieux, R. (2012). HTLV-2 APH-2 expression is correlated with proviral load but APH-2 does not promote lymphocytosis. J Infect Dis 205, 82-86.
11. Felder, M. P., Laugier, D., Yatsula, B., Dezélée, P., Calothy, G. & Marx, M. (1994). Functional and biological properties of an avian variant long terminal repeat containing multiple A to G conversions in the U3 sequence. J Virol 68, 4759-4767.
12. George, C. X. & Samuel, C. E. (1999). Human RNA-specific adenosine deaminase ADAR1 transcripts possess alternative exon 1 structures that initiate from different promoters, one constitutively active and the other interferon inducible. Proc Natl Acad Sci U S A 96, 4621-4626.
13. Grande-Pérez, A., Sierra, S., Castro, M. G., Domingo, E. & Lowenstein, P. R. (2002). Molecular indetermination in the transition to error catastrophe: systematic elimination of lymphocytic choriomeningitis virus through mutagenesis does not correlate linearly with large increases in mutant spectrum complexity. Proc Natl Acad Sci U S A 99, 12938-12943.
14. Hajjar, A. M. & Linial, M. L. (1995). Modification of retroviral RNA by double-stranded RNA adenosine deaminase. J Virol 69, 5878-5882.
15. Lehmann, K. A. & Bass, B. L. (2000). Double-stranded RNA adenosine deaminases ADAR1 and ADAR2 have overlapping specificities. Biochemistry 39, 12875-12884.
16. Li, Y., Kappes, J. C., Conway, J. A., Price, R. W., Shaw, G. M. & Hahn, B. H. (1991). Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and-defective viral genomes. J Virol 65, 3973-3985.
17. Liu, Y., George, C. X., Patterson, J. B. & Samuel, C. E. (1997). Functionally distinct double-stranded RNA-binding domains associated with alternative splice site variants of the interferon-inducible double-stranded RNA-specific adenosine deaminase. J Biol Chem 272, 4419-4428.
18. Mahieux, R. & Gessain, A. (2011). HTLV-3/STLV-3 and HTLV-4 viruses: discovery, epidemiology, serology and molecular aspects. Viruses 3, 1074-1090.
19. Martínez, I., Dopazo, J. & Melero, J. A. (1997). Antigenic structure of the human respiratory syncytial virus G glycoprotein and relevance of hypermutation events for the generation of antigenic variants. J Gen Virol 78, 2419-2429.
20. Melcher, T., Maas, S., Herb, A., Sprengel, R., Higuchi, M. & Seeburg, P. H. (1996). RED2, a brain-specific member of the RNA-specific adenosine deaminase family. J Biol Chem 271, 31795-31798.
21. Murphy, D. G., Dimock, K. & Kang, C. Y. (1991). Numerous transitions in human parainfluenza virus 3 RNA recovered from persistently infected cells. Virology 181, 760-763.
22. O'Hara, P. J., Nichol, S. T., Horodyski, F. M. & Holland, J. J. (1984). Vesicular stomatitis virus defective interfering particles can contain extensive genomic sequence rearrangements and base substitutions. Cell 36, 915-924.
23. Patterson, J. B., Cornu, T. I., Redwine, J., Dales, S., Lewicki, H., Holz, A., Thomas, D., Billeter, M. A. & Oldstone, M. B. (2001). Evidence that the hypermutated M protein of a subacute sclerosing panencephalitis measles virus actively contributes to the chronic progressive CNS disease. Virology 291, 215-225.
24. Phuphuakrat, A., Kraiwong, R., Boonarkart, C., Lauhakirti, D., Lee, T. H. & Auewarakul, P. (2008). Double-stranded RNA adenosine deaminases enhance expression of human immunodeficiency virus type 1 proteins. J Virol 82, 10864-10872.
25. Rueda, P., García-Barreno, B. & Melero, J. A. (1994). Loss of conserved cysteine residues in the attachment (G) glycoprotein of two human respiratory syncytial virus escape mutants that contain multiple A-G substitutions (hypermutations). Virology 198, 653-662.
26. Samuel, C. E. (2001). Antiviral actions of interferons. Clin Microbiol Rev 14, 778-809.
27. Slattery, J. P., Franchini, G. & Gessain, A. (1999). Genomic evolution, patterns of global dissemination, and interspecies transmission of human and simian T-cell leukemia/lymphotropic viruses. Genome Res 9, 525-540.
28. Suspene, R., Henry, M., Guillot, S., Wain-Hobson, S. & Vartanian, J. P. (2005). Recovery of APOBEC3-edited human immunodeficiency virus GAA hypermutants by differential DNA denaturation PCR. J Gen Virol 86, 125-129.
29. Suspene, R., Renard, M., Henry, M., Guétard, D., Puyraimond-Zemmour, D., Billecocq, A., Bouloy, M., Tangy, F., Vartanian, J. P. & Wain-Hobson, S. (2008). Inversing the natural hydrogen bonding rule to selectively amplify GC-rich ADAR-edited RNAs. Nucleic Acids Res 36, e72.
30. Suspene, R., Petit, V., Puyraimond-Zemmour, D., Aynaud, M. M., Henry, M., Guétard, D., Rusniok, C., Wain-Hobson, S. & Vartanian, J. P. (2011). Double-stranded RNA adenosine deaminase ADAR-1-induced hypermutated genomes among inactivated seasonal influenza and live attenuated measles virus vaccines. J Virol 85, 2458-2462.
31. Taylor, D. R., Puig, M., Darnell, M. E., Mihalik, K. & Feinstone, S. M. (2005). New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1. J Virol 79, 6291-6298.
32. Tenoever, B. R., Ng, S. L., Chua, M. A., McWhirter, S. M., García-Sastre, A. & Maniatis, T. (2007). Multiple functions of the IKK-related kinase IKKe in interferon-mediated antiviral immunity. Science 315, 1274-1278.
33. Wang, Y. & Samuel, C. E. (2009). Adenosine deaminase ADAR1 increases gene expression at the translational level by decreasing protein kinase PKR-dependent eIF-2a phosphorylation. J Mol Biol 393, 777-787.
34. Wang, Y., Zeng, Y., Murray, J. M. & Nishikura, K. (1995). Genomic organization and chromosomal location of the human dsRNA adenosine deaminase gene: the enzyme for glutamate-activated ion channel RNA editing. J Mol Biol 254, 184-195.
35. Wattel, E., Vartanian, J. P., Pannetier, C. & Wain-Hobson, S. (1995). Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy. J Virol 69, 2863-2868.
36. Wong, T. C., Ayata, M., Hirano, A., Yoshikawa, Y., Tsuruoka, H. & Yamanouchi, K. (1989). Generalized and localized biased hypermutation affecting the matrix gene of a measles virus strain that causes subacute sclerosing panencephalitis. J Virol 63, 5464-5468.
37. Wong, T. C., Ayata, M., Ueda, S. & Hirano, A. (1991). Role of biased hypermutation in evolution of subacute sclerosing panencephalitis virus from progenitor acute measles virus. J Virol 65, 2191-2199.